alpha-aminopyridine has been researched along with Depression in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Chen, Z; Huang, C; Lu, J; Lu, X; Tong, L; Wang, D; Ye, T; Yuan, X | 1 |
| Chen, W; Fu, HR; Gao, YF; Wang, H; Wang, L; Wang, XD; Xu, XY; Xu, Y; Zhang, FF; Zhang, HT; Zhang, JG | 1 |
| Goralski, JL; McKinzie, CJ; Noah, TL; Prieur, MB; Retsch-Bogart, GZ | 1 |
| Bilello, JA; Dickerson, BC; English, BA; Ereshefsky, L; Fava, M; Flynn, M; Freeman, MP; Gertsik, LG; Hoeppner, BB; Johe, K; Johnstone, J; Kinrys, G; Makris, N; Mischoulon, D; Thurmond, LM | 1 |
| Costes, N; Didelot, A; Gilliam, F; Hammers, A; Lothe, A; Ryvlin, P; Saoud, M | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Carilla-Durand, E; Colpaert, F; Depoortère, R; Kleven, MS; Koek, W; Newman-Tancredi, A; Vacher, B | 1 |
| Long, BC; Miller, BH; Pletcher, MT; Schultz, LE | 1 |
| Ballanger, B; Broussolle, E; Eche, J; Klinger, H; Le Bars, D; Lerond, J; Sgambato-Faure, V; Thobois, S; Tremblay, L; Vallet, AE | 1 |
| Harrison, AA; Liem, YT; Markou, A | 1 |
1 trial(s) available for alpha-aminopyridine and Depression
| Article | Year |
|---|---|
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.
Topics: Adult; Aminopyridines; Biomarkers, Pharmacological; Depression; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2016 |
8 other study(ies) available for alpha-aminopyridine and Depression
| Article | Year |
|---|---|
Antidepressive properties of macrophage-colony stimulating factor in a mouse model of depression induced by chronic unpredictable stress.
Topics: Aminopyridines; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Hippocampus; Macrophage Activation; Macrophage Colony-Stimulating Factor; Male; Mice; Mice, Inbred C57BL; Microglia; Minocycline; Pyrroles; Stress, Psychological | 2020 |
The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
Topics: Alzheimer Disease; Aminopyridines; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Benzamides; Cerebral Cortex; Cyclopropanes; Depression; Disease Models, Animal; Hippocampus; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphodiesterase 4 Inhibitors; Presenilin-1; Recognition, Psychology | 2020 |
Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis.
Topics: Adolescent; Aminophenols; Aminopyridines; Antidepressive Agents; Anxiety; Benzodioxoles; Child; Cognitive Behavioral Therapy; Cystic Fibrosis; Depression; Drug Combinations; Female; Humans; Membrane Transport Modulators; Quinolones; Suicidal Ideation; Suicide, Attempted; Withholding Treatment | 2017 |
Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.
Topics: Adult; Aminopyridines; Brain; Cerebral Cortex; Depression; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists | 2008 |
F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.
Topics: Aminopyridines; Animals; Antidepressive Agents; Corticosterone; Depression; Hypothermia; Male; Models, Animal; Molecular Targeted Therapy; Motor Activity; Piperidines; Prefrontal Cortex; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serotonin; Serotonin 5-HT1 Receptor Agonists; Stress, Physiological; Swimming | 2010 |
Quantitative trait locus analysis identifies Gabra3 as a regulator of behavioral despair in mice.
Topics: Aminopyridines; Animals; Behavior, Animal; Crosses, Genetic; Depression; Genotype; Hindlimb Suspension; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Quantitative Trait Loci; Receptors, GABA-A; Thiophenes | 2010 |
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.
Topics: Adult; Aged; Aminopyridines; Brain; Depression; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Piperazines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists | 2012 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2001 |